Meal Timing and Sleep for Metabolic Health in Healthy Subjects
(DT2 Trial)
Trial Summary
What is the purpose of this trial?
This study examines the acute impact of eating an "early" versus "late" dinner. "Early" and "late" will be customized to individuals based on the individuals' own circadian rhythms. Healthy adults will have the adults' circadian rhythm assessed by measuring the adults' dim light melatonin onset (DLMO). Based on the timing of DLMO, participants will be randomized to eating dinner before DLMO or after DLMO. The investigators will also compare the effects of delaying sleep relative to dinner time. Participants will eat meals in the laboratory and have serial plasma samples collected to examine profiles of free fatty acids, glucose, insulin, triglycerides, and oxidation of dietary fat.
Will I have to stop taking my current medications?
The trial requires that you do not use medications that can affect circadian rhythm, such as beta blockers and melatonin. If you are taking these, you would need to stop before participating.
What data supports the effectiveness of the treatment involving meal timing and sleep for metabolic health?
Research suggests that eating earlier in the day and aligning meal times with natural body rhythms can help improve metabolic health and prevent obesity. Studies show that having dinner earlier, especially several hours before sleep, is linked to better weight management and metabolic function.12345
Is meal timing generally safe for humans?
Research on meal timing, such as having dinner earlier or later, has primarily focused on its effects on sleep and metabolic health rather than safety concerns. No specific safety issues have been reported in studies involving healthy volunteers, suggesting that adjusting dinner timing is generally safe for humans.12678
How does the treatment of meal timing and sleep differ from other treatments for metabolic health?
This treatment is unique because it focuses on aligning meal timing with the body's natural circadian rhythms (internal body clocks) to improve metabolic health, rather than relying on medications or supplements. By adjusting when meals are consumed in relation to sleep, it aims to optimize metabolic processes and prevent disorders, which is a novel approach compared to traditional treatments.127910
Research Team
Jonathan Jun, MD
Principal Investigator
Johns Hopkins University
Eligibility Criteria
This trial is for healthy adults aged 18-30, with a BMI of 18-30 kg/m2 and normal sleep patterns (bedtime before 1:00 A.M. and mid-sleep before 5 A.M.). Participants should not be smokers or have conditions like diabetes, sleep disorders, GERD that affects eating near bedtime, or use medications affecting circadian rhythms.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 3-arm randomized crossover study to assess the metabolic impact of early and late dinner times relative to DLMO, with serial blood sampling and sleep studies
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Early dinner
- Late Dinner
- Late Dinner + Late Sleep
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
National Cancer Institute (NCI)
Collaborator
National Marrow Donor Program
Collaborator
University of Arkansas
Collaborator